Press "Enter" to skip to content

New patent for Dexcel Pharma drug LANSOPRAZOLE

0
Copyright © DrugPatentWatch. Originally published at New patent for Dexcel Pharma drug LANSOPRAZOLE

Annual Drug Patent Expirations for LANSOPRAZOLE
Annual Drug Patent Expirations for LANSOPRAZOLE

Lansoprazole is a drug marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Breckenridge, Dr Reddys Labs Ltd, Hetero Labs Ltd Iii, Inventia, Krka Tovarna Zdravil, Lannett Co Inc, Mylan, Mylan Pharms Inc, Natco Pharma Ltd, Perrigo R And D, Sandoz, Sun Pharm, Teva Pharms, Wockhardt Ltd, Wockhardt Usa, Xiromed, Zydus Hlthcare, Ani Pharms, Dexcel Pharma, Teva Pharms Usa, Zydus Pharms, Rising, and Sandoz Inc and, and is included in thirty-two NDAs. It is available from seventy suppliers.

The generic ingredient in LANSOPRAZOLE is amoxicillin; clarithromycin; lansoprazole. Seventy suppliers are listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Dexcel Pharma drug LANSOPRAZOLE
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions